Home Capital Broker's Calls

Analysts positive on Yangzijiang following strategic review of investment arm

Felicia Tan
Felicia Tan8/12/2021 3:31 PM GMT+08  • 4 min read
Analysts positive on Yangzijiang following strategic review of investment arm
CGS-CIMB and DBS have kept "add" or "buy" while OCBC has recommended "hold" on YZJ with a higher TP estimate.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Analysts from CGS-CIMB Research and DBS Group Research have reiterated “add” and “buy” on Mainboard-listed Yangzijiang after the group reported 39% y-o-y higher earnings of RMB1.6 billion ($335.1 million) for the 1HFY2021 ended June on Aug 5.

The results surpassed the expectations of both brokerages.

CGS-CIMB analyst Lim Siew Khee has maintained her target price of $1.91 in an Aug 6 report after increasing her estimate from $1.63 in a previous report dated Aug 2.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.